All Essays

Week in Review

Week in Review

President Trump signs executive order on financial technology, EPA moves to rescind a drinking water safety regulation, and more…

When Should Policymakers Consider Voluntary Regulation?

When Should Policymakers Consider Voluntary Regulation?

Scholar urges policymakers to adopt voluntary programs when mandatory regulation falls short.

When Algorithms Decide Who Gets Health Care

When Algorithms Decide Who Gets Health Care

Scholar argues that algorithms determining health care coverage should be more regulated.

When Law Speaks Loudest

When Law Speaks Loudest

Circumventing notice and comment during rulemaking can weaken the evidentiary basis for regulation.

Building Institutions’ Capacity to Support Children

Building Institutions’ Capacity to Support Children

A new framework would help to protect children’s interests in the policymaking process.

Congratulating TRR’s 2025-2026 Editorial Board

Congratulating TRR’s 2025-2026 Editorial Board

The Regulatory Review offers best wishes to our graduating leadership and staff.

Artificial Intelligence and Legal Alignment

Artificial Intelligence and Legal Alignment

Jack Boeglin discusses how legal principles can teach artificial intelligence how to behave better.

Restricting Gender-Affirming Care for Transgender Youth

Restricting Gender-Affirming Care for Transgender Youth

Scholars discuss the legal implications of gender-affirming care restrictions for transgender minors.

Week in Review

Week in Review

The Virginia Supreme Court blocks new redistricting, FDA seeks input on using AI in clinical trials, and more…

The Future of Interplanetary Risk Regulation

The Future of Interplanetary Risk Regulation

Scholars argue that increased interplanetary space exploration requires a novel approach to regulation.

Sharing the Private Market Pie

Sharing the Private Market Pie

Scholar warns that opening private markets to ordinary individuals could leave these less sophisticated investors with all the risk and less reward.

Judicial Deference and FDA

Judicial Deference and FDA

Scholar argues that limited judicial deference to agencies may matter less for FDA than health experts fear.